TACR1 and attention deficit-hyperactivity disorder: Collectively, these findings lead to the prediction that impulsive behaviour of ADHD patients with TACR1 polymorphism(s), but not that of other subjects, might be diminished by a dose of methylphenidate that does not impair their attention.